The UK is one of the heaviest nations in Europe now with 64 per cent of the population overweight or obese, and one in four ...

The weight-loss jab Wegovy may carry the highest risk of sudden sight loss compared to other semaglutide drugs such as ...

The weight-loss jab Wegovy may carry the highest risk of sudden sight loss compared to other semaglutide drugs such as ...

Researchers found that the odds of developing an eye condition that leads to vision loss were about 5 times higher among ...

Losing weight with the help of a prescription weight loss drug continues to increase in popularity. According to recent K FF polls, about one in eight U.S. adults takes a GLP-1 medication for weight ...

Wegovy is a Food and Drug Administration-approved weight loss medication for people with obesity or those who are overweight with weight-related health conditions. In recent years, interest in ...

The weight-loss jab Wegovy may carry the highest risk of sudden sight loss compared to other semaglutide drugs such as Ozempic, according to new analysis. The odds of having a so-called “eye stroke” ...

Officials wrote that Novo Nordisk had failed to failed to report ‘serious and unexpected’ adverse drug experiences ...

There are currently thought to be about 1.6 million people on weight-loss drugs in the UK. Some people are able to get the injections - the most popular are called Mounjaro and Wegovy - through the ...

Wegovy (semaglutide) does come in a pill form. In December of 2025, the Food and Drug Administration (FDA) approved Wegovy as an oral tablet. Wegovy injections and tablets contain the same active ...

As an increasing number of patients come forward with claims that their vision has been permanently impacted by weight loss jabs, eye experts have issued a vital statistical warni ...

A Cambridge University study found people who stop taking weight loss jabs such as Mounjaro and Wegovy regain almost two-thirds of the weight they lost ...